вывод сеткой



The company Stentys S.A. was founded in 2006 for the development and production of coronary stents with the property of adaptive apposition - Self-Aporing ® Stent System
These stents are able to change the diameter after installation without the need for balloon post-dilatation, which facilitates the correct choice of the stent size for myocardial infarction and for certain anatomical characteristics of the affected area - the left coronary artery trunk, bifurcations, ectatic artery transformation, and other recalibration options.
The program of clinical trials, in which more than 2,500 patients participated, demonstrated excellent angiographic and long-term results of stenting, as well as high safety of stents with adaptive apposition by Stentys S.A.

Stents with adaptive apposition simplify the choice of stent size for myocardial infarction

Coronary stent with medication of X-position S for complex lesions.
x position
Coronary stent X-Position (BMS or DES, Sirolimus) by Stentys S.A.